Shamim Ruff, Director at REATA PHARMACEUTICALS INC (RETA), sold 11,480 shares at $83.73 ($961K) on 2023-03-10, disclosed to the SEC on 2023-03-13.
Open-market sale of $961k RETA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.73 | 5,740 | $481K | 50.0% |
| 2 | $83.73 | 5,740 | $481K | 50.0% |
| Total | $83.73 avg | 11,480 | $961K | 100% |
| Filing → |
| SRPT | SELL | 2017-10-05 | $575K | — | Filing → |
| SRPT | SELL | 2017-07-21 | $522K | — | Filing → |
| SRPT | SELL | 2016-09-30 | $439K | — | Filing → |